For B-cell lymphoma, high novelty targets are RPS7, RPLP0, RPS23, RPS12, RPL10A, RPS5, RPS16, MYCPB2, RPL35, CD22, MDN1, RPS15, and WDY4. This evidence concerns the gene RPL35 and B-cell non-Hodgkin lymphoma.